Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2,181,288,547
-
Number of holders
-
1,132
-
Total 13F shares, excl. options
-
199,549,854
-
Shares change
-
-5,784,145
-
Total reported value, excl. options
-
$16,868,395,196
-
Value change
-
-$491,947,942
-
Put/Call ratio
-
62%
-
Number of buys
-
420
-
Number of sells
-
-515
-
Price
-
$84.53
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q2 2022
1,227 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q2 2022.
NOVARTIS AG - Ordinary Shares (NVS) has 1,132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 199,549,854 shares
of 2,181,288,547 outstanding shares and own 9.1% of the company stock.
Largest 10 shareholders include Dodge & Cox (22,552,769 shares), PRIMECAP MANAGEMENT CO/CA/ (17,604,080 shares), LOOMIS SAYLES & CO L P (15,485,220 shares), Fisher Asset Management, LLC (11,246,080 shares), FRANKLIN RESOURCES INC (7,488,174 shares), BANK OF AMERICA CORP /DE/ (7,424,251 shares), MORGAN STANLEY (6,398,786 shares), DIMENSIONAL FUND ADVISORS LP (6,037,514 shares), WELLINGTON MANAGEMENT GROUP LLP (4,605,522 shares), and Boston Partners (4,584,318 shares).
This table shows the top 1,132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.